Shandong Lukang Pharmaceutical Co., Ltd. Class ASSE: 600789

Annual Report on Continuous Supervision for 2025 of Shandong Lukang Pharmaceutical Co., Ltd. by China International Capital Corporation Limited

· Issued by Shandong Lukang Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange
Annual Report on Continuous Supervision for 2025 of Shandong Lukang Pharmaceutical Co., Ltd. by China International Capital Corporation Limited

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Company analysis